Evaluation of NovaSure® global endometrial ablation in symptomatic adenomyosis: A longitudinal study with a 36 month follow-up

Charles-André Philip, Charles‐André Philip, Marine Le Mitouard, Laurine Maillet, L. Maillet, Pierre de Saint-Hilaire, Cyril Huissoud, Marion Cortet, Gil Dubernard
European journal of obstetrics, gynecology, and reproductive biology · 2018 · vol. 227 , pp. 46–51 · doi:10.1016/j.ejogrb.2018.04.001 · PMID:29886317 · W2795869367
article OA: closed CC0 ⤵ 16 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This longitudinal study evaluated the NovaSure® global endometrial ablation procedure in patients with symptomatic adenomyosis, following outcomes for up to 36 months.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

dysmenorrheaadenomyosis

MeSH descriptors

Adenomyosis Dysmenorrhea Endometrial Ablation Techniques Adenomyosis Adult Dysmenorrhea Endometrial Ablation Techniques Female Follow-Up Studies Humans Longitudinal Studies Middle Aged Treatment Outcome

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (40)

Cited by (16)

Source provenance

europepmc
last seen: 2026-06-16T06:07:01.518242+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:19:43.094626+00:00
unpaywall
last seen: 2026-06-16T06:25:30.133384+00:00
License: CC0 · commercial use OK